-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UITEkvDkmDtyPj0K9oqtZsoVRPP31EOHlTvpCVMnpZO/sw0aV1gk7ckP038PzZV4 RFxqtIb+R972vq+NhImd4A== 0001094891-04-000032.txt : 20040128 0001094891-04-000032.hdr.sgml : 20040128 20040128165809 ACCESSION NUMBER: 0001094891-04-000032 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040128 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIPID SCIENCES INC/ CENTRAL INDEX KEY: 0000071478 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 430433090 STATE OF INCORPORATION: AZ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78017 FILM NUMBER: 04549806 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 925-249-4000 MAIL ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 FORMER COMPANY: FORMER CONFORMED NAME: NZ CORP DATE OF NAME CHANGE: 20000810 FORMER COMPANY: FORMER CONFORMED NAME: NEW MEXICO & ARIZONA LAND CO DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MDB CAPITAL GROUP LLC CENTRAL INDEX KEY: 0001069174 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 100 WILSHIRE BLVD SUITE 1750 CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: 3109175656 MAIL ADDRESS: STREET 1: 100 WILSHIRE BLVD SUITE 1750 CITY: SANTA MONICA STATE: CA ZIP: 90401 SC 13D/A 1 lipidmdb13dam1.txt AMENDMENT NO. 1 TO SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------------------------ SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(a) (Amendment No. 1)* Lipid Sciences, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, no par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 53630P 10 1 - -------------------------------------------------------------------------------- (CUSIP Number) - -------------------------------------------------------------------------------- Christopher A. Marlett with a copy to: MDB Capital Group, LLC Andrew D. Hudders, Esq. 401 Wilshire Boulevard, Suite 1020 Graubard Miller Santa Monica, California 90401 600 Third Avenue - 32nd Floor (310) 526-5005 New York, New York 10016 (212) 816-8614 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 27, 2004 ------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D - ----------------------- ------------------------ CUSIP No. 53630P 10 1 Page 2 of 6 Pages - ----------------------- ------------------------ - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 1 MDB Capital Group, LLC I.D. No. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)|_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION California - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF SHARES 1,000,000 BENEFICIALLY OWNED BY -------------------------------------------------------- EACH REPORTING 8 SHARED VOTING POWER PERSON WITH -0- BENEFICIALLY OWNED BY -------------------------------------------------------- EACH REPORTING 9 SOLE DISPOSITIVE POWER PERSON WITH 1,000,000 -------------------------------------------------------- 10 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,000,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*|_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.1% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* BD - -------------------------------------------------------------------------------- SCHEDULE 13D - ----------------------- ------------------------ CUSIP No. 53630P 10 1 Page 3 of 6 Pages - ----------------------- ------------------------ - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 1 Christopher A. Marlett I.D. No. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)|_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF SHARES 1,200,000 BENEFICIALLY OWNED BY -------------------------------------------------------- EACH REPORTING 8 SHARED VOTING POWER PERSON WITH -0- BENEFICIALLY OWNED BY -------------------------------------------------------- EACH REPORTING 9 SOLE DISPOSITIVE POWER PERSON WITH 1,200,000 -------------------------------------------------------- 10 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,200,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*|_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.9% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- SCHEDULE 13D - ----------------------- ------------------------ CUSIP No. 53630P 10 1 Page 4 of 6 Pages - ----------------------- ------------------------ Item 1. Name of Issuer: This Amendment No. 1 to Schedule 13D originally dated January 14, 2004 (the "Schedule") relates to the common stock, no par value, ("Common Stock") of Lipid Sciences, Inc., an Arizona corporation (the "Issuer"). The principal executive offices of the Issuer are located at 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566. Item 2. Identity and Background. This Schedule is filed jointly on behalf of MDB Capital Group, LLC, a California limited liability company ("MDB"), and Christopher A. Marlett. Mr. Marlett is deemed to have beneficial ownership of any shares beneficially owned by MDB as a result of being a control person of MDB. Mr. Marlett holds certain of the shares being reported upon in a living trust over which he is the controlling person. MDB and Mr. Marlett are sometimes collectively referred to herein as "Reporting Persons." MDB is a licensed broker and dealer. MDB is managed by Mr. Marlett, Dyana Williams Marlett and Anthony DiGiandomenico. The address of the principal business and principal office of the Reporting Persons and Ms. Marlett and Mr. DiGiandomenico is 401 Wilshire Boulevard, Suite 1020, Santa Monica, California 90401. The principal occupation of each of Ms. Marlett and Mr. DiGiandomenico is being a manager of MDB. Mr. Marlett is a citizen of the United States. MDB is a California limited liability company. During the last five years, none of the Reporting Persons has been: (a) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (b) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 3. Source and Amount of Funds and Other Consideration. No Common Stock was acquired during the prior 60 days. No change to prior disclosure. Item 4. Purpose of Transaction. The transactions being reported upon are the sale of some of the Common Stock held by the Reporting Persons and the fact that as of the date of this Amendment No.1 they are no longer required to report on a Schedule 13D in respect of the Common Stock. SCHEDULE 13D - ----------------------- ------------------------ CUSIP No. 53630P 10 1 Page 5 of 6 Pages - ----------------------- ------------------------ Item 5. Interest in Securities of the Issuer. The following sales of the Common Stock were made by the reporting persons during the last 60 days. The sales were made in the public market, over the Nasdaq market. MDB Trade Date No. Shares Sold Price ---------- --------------- ----- 1/23/2004 240,005 $5.98 1/26/2004 60,599 $6.43 Christopher Marlett Living Trust 1/21/2004 25,000 $5.26 1/22/2004 45,979 $5.25 1/23.2004 47,500 $6.02 1/26/2004 100,000 $6.54 As a result of the above sales by the trust and MDB, MDB owns 1,000,000 shares of Common Stock representing 4.1% of the outstanding Common Stock, and Mr. Marlett, through his living trust, owns 200,000 shares of Common Stock representing .8% of the outstanding Common Stock. Mr. Marlett as the controlling member of MDB is deemed to have voting and dispositive authority over all the shares held by MDB. Therefore, he has beneficial ownership of 1,200,000 shares of Common Stock representing 4.9% of the outstanding Common Stock. Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. Except for the Joint Filing Agreement, neither MDB or Mr. Marlett have any contracts, arrangements, understandings or relationships with respect to the Common Stock. Item 7. Material to be filed as Exhibits. Exhibit 1 Joint Filing Agreement, dated December 10, 2001, between MDB Capital Group, LLC and Christopher A. Marlett (previously filed in Schedule 13D filed in respect of the event dated November 29, 2001, and incorporated herein by reference). SCHEDULE 13D - ----------------------- ------------------------ CUSIP No. 53630P 10 1 Page 6 of 6 Pages - ----------------------- ------------------------ SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. Dated: January 28, 2004 MDB Capital Group, LLC By: /s/ Christopher A. Marlett ------------------------------------- Name: Christopher A. Marlett ------------------------------------- Its: Manager ------------------------------------- /s/ Christopher A. Marlett ------------------------------------- Christopher A. Marlett -----END PRIVACY-ENHANCED MESSAGE-----